South Korea Is First Country to Test Covid-19 Antibody Drug

Celltrion estimates that the trials will be completed by the end of this year and that the drug will be ready for commercialization by early 2021.

RIO DE JANEIRO, BRAZIL - On Friday, July 17th South Korea became the first country to approve human trials of an antibody-based medication against the novel coronavirus.

The . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?